What is Tandem Diabetes Care?
Tandem Diabetes Care is a diabetes insulin delivery company serving providers, payers, patients, labs, hospitals, researchers, or life-sciences commercial teams.
- Category
- Diabetes insulin delivery
- Headquarters
- San Diego, CA
- Founded
- See company profile and filings
- Employees
- Mid-market / scaled operating company
- Total funding
- Public company
- Status
- Public company; Nasdaq: TNDM
What is Tandem Diabetes Care?
Tandem Diabetes Care is a diabetes insulin delivery company headquartered in San Diego, CA.
Tandem Diabetes Care operates in diabetes insulin delivery and has reached a scaled mid-market profile rather than an early startup footprint. Its official site and investor/company materials position the business around t:slim X2, Mobi, Control-IQ, with customers using the company for repeatable operating workflows rather than one-off projects.
For sellers, Tandem Diabetes Care is useful to profile because the buying center is large enough to include specialized finance, IT, operations, procurement, and line-of-business owners. The company status is Public company; Nasdaq: TNDM, so the best live signals are current company announcements, investor materials where available, hiring patterns, product launches, and partner ecosystem activity.
What does Tandem Diabetes Care offer?
Tandem Diabetes Care's profile centers on t:slim X2, Mobi, Control-IQ, Tandem Source.
- t:slim X2· Diabetes insulin delivery
- Mobi· Diabetes insulin delivery
- Control-IQ· Diabetes insulin delivery
- Tandem Source· Diabetes insulin delivery
- Infusion sets· Diabetes insulin delivery
- Mobile bolus· Diabetes insulin delivery
How does Tandem Diabetes Care make money?
Tandem Diabetes Care makes money through commercial activity tied to diabetes insulin delivery.
Tandem Diabetes Care monetizes through the commercial model common to diabetes insulin delivery: a mix of product sales, subscriptions, usage, services, channel programs, or transaction volume depending on the operating unit. Public list pricing is not always available, so enterprise buyers usually evaluate packaging, contract scope, geographic coverage, implementation services, and support commitments.
The practical growth levers are account expansion, new product attach, channel reach, retention, and operational efficiency. For outbound teams, that means relevant sales angles usually connect to productivity, integration, compliance, data quality, margin improvement, customer experience, or faster execution across distributed teams.
Who leads Tandem Diabetes Care?
Tandem Diabetes Care's named executives should be verified on the official leadership or investor-relations page before outreach.
- Tandem Diabetes Care executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Tandem Diabetes Care finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, and budget discipline.
- Tandem Diabetes Care technology or operations leadershipTechnology, product, operations, or security leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operational-improvement purchases.
How do you contact Tandem Diabetes Care's leadership?
Tandem Diabetes Care should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.tandemdiabetes.com- Tandem Diabetes Care investor relationsInvestor relations / corporate contactcontact via https://www.tandemdiabetes.com
- Tandem Diabetes Care sales or partnershipsCommercial contact routecontact via https://www.tandemdiabetes.com
- Tandem Diabetes Care media relationsMedia or communications contact routecontact via https://www.tandemdiabetes.com
How is Tandem Diabetes Care funded?
Tandem Diabetes Care's current status is Public company; Nasdaq: TNDM.
Tandem Diabetes Care's current capital profile is best understood through its current status: Public company; Nasdaq: TNDM. If the company is public, the relevant financing signals are annual reports, quarterly results, debt disclosures, buybacks, acquisitions, and capital allocation commentary rather than venture rounds.
If the company is private or recently acquired, the important seller signal is ownership context: sponsors or strategic owners often push standardization, operating metrics, procurement discipline, and integration work. In either case, budget timing should be inferred from current company announcements, earnings materials, product launches, hiring, and strategic initiatives rather than stale funding databases.
How did Tandem Diabetes Care get here?
Tandem Diabetes Care's history should be read through founding, scale-up, public/private ownership, and current product or market focus.
- FoundingTandem Diabetes Care is foundedThe company begins building in diabetes insulin delivery.
- Scale-upCommercial footprint expandsTandem Diabetes Care broadens its product, customer, or geographic reach.
- Capital marketsPublic company; Nasdaq: TNDMOwnership and financing context shapes procurement, reporting, and operating priorities.
- 2025Mid-market operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, current status, and public source references.
Who are Tandem Diabetes Care's competitors?
Tandem Diabetes Care competes with larger platform incumbents and focused specialists in diabetes insulin delivery.
- MedtronicGlobal medical-technology incumbent with broad device and care-management scale.
- Boston ScientificLarge medical-device company competing across interventional specialties.
- AbbottHealthcare company with diagnostics, diabetes care, devices, and nutrition scale.
- Johnson & Johnson MedTechLarge medtech and pharmaceutical incumbent with global commercial reach.
- StrykerOrthopedics, neurotechnology, and surgical equipment competitor with hospital relationships.
Tandem Diabetes Care — frequently asked questions
